Gut Health
Conditions
Brief summary
This is a virtual, single-arm clinical trial that will last 4-weeks. Participants will take the supplement daily and complete questionnaires at baseline, week 2, and week 4. Participants will provide photos of their face and stomach at baseline and week 4. Gut health and associated health outcomes, including brain, skin, and immune function, will be evaluated at baseline and at each check-in. Likert scale responses will be statistically compared from baseline to each check-in. Participant responses on product feedback will be presented as % scores. Baseline and endline photos from each study part will be provided by participants.
Interventions
OTHERCombined pre-, pro-, and post-biotic supplement
Participants will take 2 capsules daily with water, with their first meal of the day.
Sponsors
Beekeeper's Naturals Inc
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Men or women * 18 years of age or older * Experience at least one of the following symptoms: regular bloating/gas, irregular bowel movements, heartburn, or poor digestive health * Generally healthy
Exclusion criteria
* Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders. * Allergic to bees, bee products, poplar tree products, or balsam of Peru * Anyone with known severe allergic reactions. * Women who are pregnant, breastfeeding or attempting to become pregnant * Unwilling to follow the study protocol. * Has introduced any new forms of medication or supplements targeting gut health within the last 3 months * Has taken antibiotics in the last 3 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in participant-reported gastrointestinal symptoms [Time Frame: Baseline to 4 weeks] | 4 weeks | Assessed via study-specific questionnaires to gather information on improvements in bloating, digestion, stool regularity, stool quality, and gas. Survey-based assessments (0-5, 0-6 point scale) of changes in bloating, digestion, stool regularity, stool quality, and gas. |
| Change in scores on the Gastrointestinal Symptom Rating Scale (GSRS) [Time Frame: Baseline to 4 | 4 weeks | Use of validated questionnaire the GSRS to assess gastrointestinal symptoms.The GSRS is a disease-specific instrument of 15 items combined into five symptom clusters reporting on Reflux, Abdominal pain, Indigestion, Diarrhoea and Constipation. The GSRS has a seven-point graded Likert-type scale where 1 represents no symptoms and 7 represents severe symptoms. |
Countries
United States
Outcome results
None listed